Novacyt

Actualités

Accueil | Actualités

Actualités et médias chez Novacyt Group

17 Nov 2023

Yourgene Health devient un partenaire compatible avec PacBio : permettant aux clients de PacBio d’optimiser la sélection de taille des bibliothèques de séquençage à longue lecture

Communiqués de presse

Yourgene Health Logo
Yourgene

Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries Yourgene’s LightBench® instrument offers precise and accurate target enrichment of PacBio HiFi SMRTbell sequencing libraries increasing HiFi sequencing yields Manchester, UK, 17 November 2023: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group,…

Read more

09 Nov 2023

Yourgene Health et Laboriad lancent le test prénatal non invasif au Maroc

Communiqués de presse

Yourgene Health Logo
Yourgene

Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing to expectant parents Manchester, UK, and Rabat, MOROCCO, 09 November 2023: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, has installed the first non-invasive prenatal testing (NIPT)…

Read more

07 Nov 2023

Certification IVDR obtenue pour le test de génotypage des variantes du gène DPYD : premier produit de ce type à se conformer aux nouvelles exigences IVDR

Communiqués de presse

Yourgene Health Logo
Yourgene

IVDR certification achieved for DPYD genotyping assay First product of its kind to conform with new IVDR requirements Yourgene Health (part of the Novacyt group), an international specialist in clinical diagnostics, confirms – IVDR accreditation under the new requirements of the In Vitro Diagnostic Regulation (“IVDR”) for its DPYD genotyping assay, which helps identify cancer patients at…

Read more

Nouvelles des investisseurs

Pour les nouvelles des investisseurs via RNS, veuillez cliquer sur le bouton ci-dessous.

Voir plus